Diergo en es it fr

Diergo Brand names, Diergo Analogs

Diergo Brand Names Mixture

  • No information avaliable

Diergo Chemical_Formula

C33H37N5O5

Diergo RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Diergo fda sheet

Diergo FDA

Diergo msds (material safety sheet)

Diergo MSDS

Diergo Synthesis Reference

No information avaliable

Diergo Molecular Weight

583.678 g/mol

Diergo Melting Point

No information avaliable

Diergo H2O Solubility

No information avaliable

Diergo State

Solid

Diergo LogP

No information avaliable

Diergo Dosage Forms

Liquid

Diergo Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Diergo Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Diergo Absorption

Interpatient variable and may be dependent on the administration technique

Diergo side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Diergo Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45 (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Diergo Organisms Affected

Humans and other mammals